N
Neuroelectrics
Developing a unique platform to treat brain dysfunction with cloud-based, personalized neuromodulation
About Neuroelectrics
Neuroelectrics, a Spanish company based in Barcelona, was founded in 2011 by Ana Maiques, who serves as the CEO, and her husband, Giulio Ruffini. The company emerged as a spin-off from Starlab Neuroscience Research, which was established in 2000. Both Maiques and Ruffini had previously worked at Starlab until it faced bankruptcy, leading them to establish Neuroelectrics to continue their work in brain science.
Read full description
The company develops and produces non-invasive technologies for monitoring and stimulating the brain. It operates at the intersection of neuroscience, physics, machine learning, and hardware, positioning itself as a digital brain health company. Its business model is centered on providing advanced medical devices to research institutions and clinical settings for the treatment of neurological and psychiatric disorders.
Neuroelectrics' core offering is a platform that combines wireless electroencephalography (EEG) for brain monitoring with transcranial current stimulation (tCS) for therapeutic intervention. This technology allows for personalized neuromodulation, using computational neuroscience and data science to tailor treatments for conditions such as epilepsy and depression. The aim is to create a therapeutic platform that can restore brain health through precise and individualized electrical stimulation.
At a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Barcelona, Spain
- Employees
- 64
- Open positions
- 7
- Dealroom signal
- 65.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Rehabilitation, Biotechnology, Drug Development, Neurology
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Machine Learning
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2021 | $18M | $70M | Morningside | ↗ |
| SERIES A✓Equity / VC | Nov 2020 | $18M | $72M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Neuroelectrics is 24K monthly website visits, up 33.3% over the last three months. Neuroelectrics's team declined 4.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
MassChallenge
Series A1 investor entered at this stage
Other known investors3 additional known investors
EIT Health
Starlab
Intelectium
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neuroelectrics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neuroelectrics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.